Characteristics and outcome of small cell lung cancer patients (SCLC) transformed from adenocarcinoma after tyrosine kinase inhibitor treatment

Cancer Patients ◽

Kinase Inhibitor ◽

Small Cell ◽

Small Cell Lung ◽

Lung Cancer Patients ◽

Plasma MIP-1β levels and skin toxicity in Japanese non-small cell lung cancer patients treated with the EGFR-targeted tyrosine kinase inhibitor, gefitinib

Lung Cancer ◽

10.1016/j.lungcan.2005.07.012 ◽

2005 ◽

Vol 50 (3) ◽

pp. 393-399 ◽

Cited By ~ 9

Author(s):

Hideharu Kimura ◽

Kazuo Kasahara ◽

Masaru Sekijima ◽

Tomohide Tamura ◽

Kazuto Nishio

Keyword(s):

Lung Cancer ◽

Tyrosine Kinase ◽

Small Cell Lung Cancer ◽

Cancer Patients ◽

Kinase Inhibitor ◽

Skin Toxicity ◽

Small Cell ◽

Small Cell Lung ◽

Proposal of new CT response criteria in non-small cell lung cancer patients treated with EGFR tyrosine kinase inhibitor.

Journal of Clinical Oncology ◽

10.1200/jco.2010.28.15_suppl.7035 ◽

2010 ◽

Vol 28 (15_suppl) ◽

pp. 7035-7035

Author(s):

H. Lee ◽

K. Lee ◽

M. Ahn ◽

H. Hwang ◽

J. Lee ◽

...

Keyword(s):

Lung Cancer ◽

Tyrosine Kinase ◽

Small Cell Lung Cancer ◽

Cancer Patients ◽

Kinase Inhibitor ◽

Small Cell ◽

Small Cell Lung ◽

Readministration of EGFR Tyrosine Kinase Inhibitor in Non-small Cell Lung Cancer Patients after Initial Failure, What Affects its Efficacy?

Scientific Reports ◽

10.1038/srep05996 ◽

2014 ◽

Vol 4 (1) ◽

Cited By ~ 4

Author(s):

Ze-Rui Zhao ◽

Wei li ◽

Hao Long

Keyword(s):

Lung Cancer ◽

Tyrosine Kinase ◽

Small Cell Lung Cancer ◽

Cancer Patients ◽

Kinase Inhibitor ◽

Small Cell ◽

Small Cell Lung ◽

Continuous EGFR tyrosine kinase inhibitor treatment with or without chemotherapy beyond gradual progression in non-small cell lung cancer patients

OncoTargets and Therapy ◽

10.2147/ott.s143569 ◽

2017 ◽

Vol Volume 10 ◽

pp. 4261-4267 ◽

Cited By ~ 1

Author(s):

Ling Peng ◽

Yina Wang ◽

Yemin Tang ◽

Lei Zeng ◽

Junfang Liu ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cancer Patients ◽

Kinase Inhibitor ◽

Small Cell ◽

Small Cell Lung ◽

Lung Cancer Patients ◽

BE-POSITIVE: Beyond progression after tyrosine kinase inhibitor in EGFR- positive non small cell lung cancer patients

Lung Cancer ◽

10.1016/j.lungcan.2016.02.011 ◽

2016 ◽

Vol 95 ◽

pp. 73-81 ◽

Cited By ~ 7

Author(s):

Tiziana Vavalà ◽

Alessandro Follador ◽

Marcello Tiseo ◽

Domenico Galetta ◽

Alessandro Morabito ◽

...

Keyword(s):

Lung Cancer ◽

Tyrosine Kinase ◽

Small Cell Lung Cancer ◽

Cancer Patients ◽

Cell Lung Cancer ◽

Kinase Inhibitor ◽

Small Cell ◽

Small Cell Lung ◽

Clinical Implications of High MET Gene Dosage in Non-Small Cell Lung Cancer Patients without Previous Tyrosine Kinase Inhibitor Treatment

Journal of Thoracic Oncology ◽

10.1097/jto.0b013e3182307e92 ◽

2011 ◽

Vol 6 (12) ◽

pp. 2027-2035 ◽

Cited By ~ 12

Author(s):

Ya-Ting Chen ◽

John Wen-Cheng Chang ◽

Hui-Ping Liu ◽

Tsung-Fu Yu ◽

Yu-Ting Chiu ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cancer Patients ◽

Kinase Inhibitor ◽

Gene Dosage ◽

Small Cell ◽

Clinical Implications ◽

Small Cell Lung ◽

Lung Cancer Patients ◽

Clinical responses to EGFR-tyrosine kinase inhibitor retreatment in non-small cell lung cancer patients who benefited from prior effective gefitinib therapy: a retrospective analysis

BMC Cancer ◽

10.1186/1471-2407-11-1 ◽

2011 ◽

Vol 11 (1) ◽

Cited By ~ 81

Author(s):

Satoshi Watanabe ◽

Junta Tanaka ◽

Takeshi Ota ◽

Rie Kondo ◽

Hiroshi Tanaka ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cancer Patients ◽

Kinase Inhibitor ◽

Small Cell ◽

Small Cell Lung ◽

Lung Cancer Patients ◽

Clinical Responses

9087 POSTER Clinical Responses to EGFR-tyrosine Kinase Inhibitor Retreatment in Non-small Cell Lung Cancer Patients Who Benefited Prior Gefitinib Therapy

European Journal of Cancer ◽

10.1016/s0959-8049(11)72399-1 ◽

2011 ◽

Vol 47 ◽

pp. S618-S619

Author(s):

S. Watanabe ◽

Y. Saida ◽

K. Ichikawa ◽

J. Koshio ◽

J. Baba ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cancer Patients ◽

Kinase Inhibitor ◽

Small Cell ◽

Small Cell Lung ◽

Lung Cancer Patients ◽

Clinical Responses

Novel resistance mechanisms including L1196Q, P1094H, and R1248_D1249insertion in three patients with non-small-cell lung cancer following ALK tyrosine kinase inhibitor treatment

Journal of Thoracic Oncology ◽

10.1016/j.jtho.2020.09.023 ◽

2020 ◽

Author(s):

Hiromi Furuta ◽

Mitsugu Araki ◽

Katsuhiro Masago ◽

Yukari Sagae ◽

Shiro Fujita ◽

...

Keyword(s):

Lung Cancer ◽

Tyrosine Kinase ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Kinase Inhibitor ◽

Resistance Mechanisms ◽

Small Cell ◽

Small Cell Lung ◽

PREDICTIVE FACTORS FOR LONG‐TERM RESPONDERS IN ADVANCED NON‐SMALL CELL LUNG CANCER PATIENTS TREATED WITH TYROSINE KINASE INHIBITOR

Respirology ◽

10.1111/resp.13700_281 ◽

2019 ◽

Vol 24 (S2) ◽

pp. 185-186

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cancer Patients ◽

Predictive Factors ◽

Kinase Inhibitor ◽

Small Cell ◽

Small Cell Lung ◽